Thrivent Financial for Lutherans
SLXP

Thrivent Financial for Lutherans’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Thrivent Financial for Lutherans’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,950
Closed -$569K – 1894
2014
Q4 		$569K Hold
4,950
– – ﹤0.01% 1050
2014
Q3 		$773K Hold
4,950
– – ﹤0.01% 937
2014
Q2 		$611K Buy
4,950
+50
+1% +$5.53K ﹤0.01% 1036
2014
Q1 		$508K Buy
4,900
+100
+2% +$10.2K ﹤0.01% 952
2013
Q4 		$432K Hold
4,800
– – ﹤0.01% 1053
2013
Q3 		$321K Sell
4,800
-14,200
-75% -$979K ﹤0.01% 1177
2013
Q2 		$1.26K Buy
+19,000
New +$1.09M 0.01% 665

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans's SLXP Position: Q1 2015 in Review

Thrivent Financial for Lutherans sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 4,950 shares — an estimated $569K sold.

Thrivent Financial for Lutherans first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $773K in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

  • Thrivent Financial for Lutherans reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 4,950 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $569K.
  • Thrivent Financial for Lutherans first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
  • Thrivent Financial for Lutherans's SALIX PHARMACEUTICALS LTD DEL position peaked at $773K in Q3 2014.
  • 298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2015, filed 15 May 2015.